PE20060628A1 - Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos como inhibidores de cpla2 - Google Patents

Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos como inhibidores de cpla2

Info

Publication number
PE20060628A1
PE20060628A1 PE2005000959A PE2005000959A PE20060628A1 PE 20060628 A1 PE20060628 A1 PE 20060628A1 PE 2005000959 A PE2005000959 A PE 2005000959A PE 2005000959 A PE2005000959 A PE 2005000959A PE 20060628 A1 PE20060628 A1 PE 20060628A1
Authority
PE
Peru
Prior art keywords
terreo
mol
cpla2
inhibitors
formula
Prior art date
Application number
PE2005000959A
Other languages
English (en)
Spanish (es)
Inventor
Ronald S Michalak
Mahmut Levent
Panolil Raveendranath
Alan Stockton
Mousumi Ghosh
Charles Guinosso
Christoph Dehnhardt
Michael W Winkley
Michel Cantin
Ara R Boyajian
Frederik J Vyverberg
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20060628A1 publication Critical patent/PE20060628A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE2005000959A 2004-08-19 2005-08-18 Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos como inhibidores de cpla2 PE20060628A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60312404P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
PE20060628A1 true PE20060628A1 (es) 2006-08-14

Family

ID=35219553

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000959A PE20060628A1 (es) 2004-08-19 2005-08-18 Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos como inhibidores de cpla2

Country Status (24)

Country Link
US (3) US7582772B2 (cg-RX-API-DMAC10.html)
EP (1) EP1778629B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008510707A (cg-RX-API-DMAC10.html)
KR (1) KR20070043036A (cg-RX-API-DMAC10.html)
CN (2) CN101830837A (cg-RX-API-DMAC10.html)
AR (1) AR053410A1 (cg-RX-API-DMAC10.html)
AT (1) ATE517084T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005277392A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0514431A (cg-RX-API-DMAC10.html)
CA (1) CA2576008A1 (cg-RX-API-DMAC10.html)
CR (1) CR8936A (cg-RX-API-DMAC10.html)
EC (1) ECSP077244A (cg-RX-API-DMAC10.html)
GT (1) GT200500224A (cg-RX-API-DMAC10.html)
HN (1) HN2005000474A (cg-RX-API-DMAC10.html)
IL (1) IL181364A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007002042A (cg-RX-API-DMAC10.html)
NO (1) NO20071253L (cg-RX-API-DMAC10.html)
PE (1) PE20060628A1 (cg-RX-API-DMAC10.html)
RU (1) RU2401829C2 (cg-RX-API-DMAC10.html)
SG (1) SG155214A1 (cg-RX-API-DMAC10.html)
SV (1) SV2006002200A (cg-RX-API-DMAC10.html)
TW (1) TW200609214A (cg-RX-API-DMAC10.html)
UA (1) UA85428C2 (cg-RX-API-DMAC10.html)
WO (1) WO2006023611A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
WO2008055148A2 (en) * 2006-10-31 2008-05-08 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
CL2007003143A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composicion farmaceutica que comprende un compuesto derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 5-50% de un segundo solubilizante, 10-30% de un primer diluyente y 1-15% de un segundo diluyente; proceso de prepracion; y forma de dosificacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
UA81596C2 (en) * 1999-12-09 2008-01-25 Авентис Кропсаенс Гмбх Nitro-sulfobenzamides
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
HUP0402577A3 (en) * 2001-12-03 2011-05-30 Wyeth Corp Indole derivatives as inhibitors of cytosolic phospholipase a2, process for producing them and pharmaceutical compositions containing them
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
WO2005012235A1 (en) 2003-07-29 2005-02-10 Ciba Specialty Chemicals Holding Inc. 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
CN101006048B (zh) 2011-07-06
ECSP077244A (es) 2007-03-29
KR20070043036A (ko) 2007-04-24
JP2008510707A (ja) 2008-04-10
HN2005000474A (es) 2009-04-07
AR053410A1 (es) 2007-05-09
US20060041005A1 (en) 2006-02-23
TW200609214A (en) 2006-03-16
NO20071253L (no) 2007-05-15
AU2005277392A1 (en) 2006-03-02
CN101006048A (zh) 2007-07-25
US8034960B2 (en) 2011-10-11
GT200500224A (es) 2006-03-21
EP1778629B1 (en) 2011-07-20
RU2401829C2 (ru) 2010-10-20
US7582772B2 (en) 2009-09-01
SG155214A1 (en) 2009-09-30
US20090306428A1 (en) 2009-12-10
ATE517084T1 (de) 2011-08-15
US7842837B2 (en) 2010-11-30
EP1778629A1 (en) 2007-05-02
US20110054189A1 (en) 2011-03-03
UA85428C2 (ru) 2009-01-26
CN101830837A (zh) 2010-09-15
SV2006002200A (es) 2006-05-09
BRPI0514431A (pt) 2008-06-10
CR8936A (es) 2007-04-26
RU2007105231A (ru) 2008-09-27
IL181364A0 (en) 2007-07-04
CA2576008A1 (en) 2006-03-02
MX2007002042A (es) 2007-03-29
WO2006023611A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
ES2602972T3 (es) Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe
MY136959A (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
UA93861C2 (uk) Спосіб одержання n-фенілпіразол-1-карбоксамідів та сполука аніліну
ECSP077982A (es) Proceso para la síntesis de 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
RU2009102502A (ru) Способ превращения первичных амидоспиртов в амидокарбоновые кислоты с высоким выходом, используя воду в качестве растворителя
JP2012180345A (ja) 3−ヒドロキシ−6H−ベンゾ[c]クロメン−6−オン誘導体およびその製造方法
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
DE602006005741D1 (de) Verfahren zur Herstellung von Boranen
RU2014142621A (ru) Химический способ получения спироиндолонов и их промежуточных соединений
AR048876A1 (es) Un proceso para preparar montelukast y compuestos intermedios para el mismo
CA2425165A1 (en) A process for the preparation of bis-benzazolyl compounds
JP2005514396A5 (cg-RX-API-DMAC10.html)
TW200604161A (en) Chemical process
ATE490255T1 (de) Verfahren zur herstellung von quaterrylen-3,4:13, 14-tetracarbonsäurediimiden durch direktsynthese
EA002119B1 (ru) Способ получения 4-замещенных-1н-индол-3-глиоксамидов
KR20100021321A (ko) Ν-페닐-2-피리미딘-아민 유도체의 제조방법
ATE407931T1 (de) Verbessertes verfahren zur herstellung von moxonidine
PE20061068A1 (es) Procedimiento para la preparacion de compuestos benzoxazol substituidos
JPWO2009099169A1 (ja) ケージド化合物
AR035993A1 (es) Procedimiento de acilacion de indoles
KR101162160B1 (ko) 산 무수물 및/또는 산 할로겐화물 및 삼산화 황으로부터입체 장애 2급 아미노에터 알콜을 합성하는 방법
TW200602304A (en) Method of producing α, β-unsaturated carboxylic acid compounds
CN110668921A (zh) 无光催化剂条件下硼酸衍生物需氧羟基化反应制备醇和酚的方法
JP2007523080A (ja) 立体障害第二級アミノエーテルアルコールの合成

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed